🎯
LATEST VERIFIED ALGORITHMIC EXECUTION
Quantitative engine captured a net profit of +19.26% on $OC in just 23h 32m.
AUT
$AUTL
🔒 US EquitiesAutolus Therapeutics plc
AVG HISTORICAL GAP
+0.59%
MAX GAP RECORD
-10.67%
🔒 PRO INSTITUTIONAL
AI PREDICTIVE WIN RATE
94.2%
REVEAL PRO DIRECTION ⚡
SENTINEL HISTORICAL GAP VIEWER
// $AUTL
📊 1-YEAR TIMELINE (GAPS PLOTTED)
🔮 SIMULATE SETUP 🔒
GAP INSPECTION // PLAYBACK PROTOCOL
$AUTL
HISTORICAL GAP OCCURRENCE
Analyzing price jump between T-1 close and opening auction.
EVENT DATE—
GAP MAGNITUDE—
T-1 CLOSE—
OPEN PRICE—
AI DIRECTIONPRO ONLY 🔒
Bullish Opening Gap
Bearish Opening Gap
T-1 Close Baseline
CATALYSTS & GAP HISTORY
| Nov 10, 2026 Earnings Release 2026-11-10 (BEFORE OPEN (07:00)) | 🔮 UPCOMING 🔒 |
| Aug 11, 2026 Earnings Release 2026-08-11 (BEFORE OPEN) |
-1.45%
|
| May 13, 2026 Earnings Release 2026-05-13 (BEFORE OPEN) |
-0.63%
|
| Mar 27, 2026 Earnings Release 2026-03-27 (BEFORE OPEN) |
-6.20%
|
| Nov 12, 2025 Earnings Release 2025-11-12 (BEFORE OPEN) |
-10.67%
|
| Aug 12, 2025 Earnings Release 2025-08-12 (BEFORE OPEN) |
+1.21%
|
| May 07, 2025 Earnings Release 2025-05-07 (BEFORE OPEN) |
+0.00%
|
| Mar 20, 2025 Earnings Release 2025-03-20 (BEFORE OPEN) |
+3.61%
|
VOLATILITY & GAP BIAS
AVG GAP MOVE
4.2%
Bullish Gaps (8)
Bearish Gaps (5)
Neutral / Flat (1)
📖 Intelligence Summary
Autolus Therapeutics plc, a clinical-stage biopharmaceutical company, develops T cell therapies for the treatment of cancer and autoimmune diseases in the United Kingdom and internationally. The company offers AUCATZYL, a gene therapy product consisting of autologous T cells that are transduced with a lentiviral vector to express a novel anti-CD19…
NEXT UPCOMING PREDICTIVE SIGNAL
STRONG BUY / TARGET +35%
🔓 REVEAL AI SIGNAL & TARGETS ↗